Comparative Clinical and Economic Analysis of Using SYSADOA Drugs Containing Chondroitin Sulphate or Influencing Its Biosynthesis in the Treatment of Patients With Stage II Knee Osteoarthritis
FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology
doi 10.17749/2070-4909.2019.12.4.255-266
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
IRBIS